Related Experiment Video
Updated: Jul 9, 2026
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Impact of indolent inflammation on neonatal hypoxic-ischemic brain injury in mice
John D E Barks1, Yi-Qing Liu, Yu Shangguan
1Departments of Pediatrics and Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. jbarks@med.umich.edu
Abstract:
This report describes a new experimental model to evaluate the effect of a recurrent systemic inflammatory challenge, after cerebral hypoxia-ischemia in immature mice, on the progression of brain injury. Treatment with a low dose of lipopolysaccharide (E. coli O55:B5, 0.2mg/kg for 3 days, then 0.1mg/kg for 2 days) daily for 5 days after unilateral cerebral hypoxia-ischemia (right carotid ligation followed by 35min in 10% O2) in 10-day-old mice resulted in increased right forebrain tissue damage (35.6% reduction in right hemisphere volume compared to 20.6% reduction in saline-injected controls), in bilateral reductions in corpus callosum area (by 12%) and myelin basic protein immunostaining (by 19%), and in suppression of injury-related right subventricular zone cellular proliferation. The post-hypoxic-ischemic lipopolysaccharide regimen that amplified brain injury was not associated with increased mortality, nor with changes in body temperature, weight gain or blood glucose concentrations. The results of the present study demonstrate that systemic inflammation influences the evolution of tissue injury after neonatal cerebral hypoxia-ischemia and may also impair potential recovery mechanisms.
Insights
Systemic inflammation after neonatal brain injury worsens brain damage in mice. This inflammatory challenge amplified injury but did not increase mortality or alter vital signs, suggesting impaired recovery mechanisms.
Area of Science:
- Neuroscience
- Immunology
- Developmental Biology
Background:
- Neonatal brain injury, such as cerebral hypoxia-ischemia, poses significant risks for long-term neurological deficits.
- The role of systemic inflammation in exacerbating neonatal brain injury and hindering recovery remains an area of active investigation.
Purpose of the Study:
- To establish and validate a novel experimental model to investigate the impact of recurrent systemic inflammation on brain injury progression following neonatal cerebral hypoxia-ischemia.
- To assess the effects of a lipopolysaccharide (LPS) challenge on brain tissue damage, white matter integrity, and cellular proliferation in immature mice.
Main Methods:
- A model of unilateral cerebral hypoxia-ischemia was induced in 10-day-old mice.
- Mice received daily low-dose lipopolysaccharide (LPS) injections for 5 days post-insult.
- Brain tissue damage, corpus callosum area, myelin basic protein (MBP) expression, and subventricular zone (SVZ) cellular proliferation were quantified.
Main Results:
- The LPS treatment significantly increased forebrain tissue damage compared to saline-injected controls.
- Bilateral reductions in corpus callosum area and MBP immunostaining indicated white matter injury.
- Injury-related cellular proliferation in the SVZ was suppressed by the inflammatory regimen.
- The LPS regimen did not lead to increased mortality, hypothermia, weight loss, or altered blood glucose levels.
Conclusions:
- Systemic inflammation following neonatal cerebral hypoxia-ischemia exacerbates brain injury in a developing mouse model.
- The inflammatory challenge appears to impair endogenous recovery mechanisms, such as cellular proliferation in the SVZ.
- This model provides a valuable tool for studying the interplay between inflammation and brain injury in the neonatal period.
